DEA Grants Trulieve Federal Recognition, Rejects Adult-Use Retailers
Trulieve's medical dispensaries gain DEA recognition under Schedule III, while a Minnesota adult-use retailer's application is rejected, hig...
Tag
#Schedule III
DEA Fights Bid to Reopen Marijuana Rescheduling Hearing
DEA opposes rescheduling critics' motion to reopen the marijuana hearing for new testimony after a GAO report found gaps in the scheduling e...
Institutional Investors Eye Cannabis as Schedule III Move Nears
Federal marijuana rescheduling is opening the door for institutional investors to enter cannabis markets, but industry maturation and improv...
DOJ and Anti-Cannabis Groups Set Legal Timeline in Rescheduling Case
Federal officials and anti-cannabis groups filed a joint briefing schedule in the lawsuit challenging Trump's marijuana rescheduling, settin...
Washington State Updates Cannabis Rules for Schedule III Compliance
Washington cannabis regulators approved rule changes to help licensed operators comply with federal marijuana rescheduling to Schedule III, ...
DEA Expands Registration to Cannabis Manufacturers and Testing Labs
DEA has launched registration forms for medical marijuana manufacturers, distributors, and testing labs, expanding federal protections beyon...
DEA Rescheduling Hearing Paused Over Agency Evaluation Procedures
A DEA administrative law judge has paused the federal cannabis rescheduling hearing to consider adding a GAO report that found the DEA and F...
Legislation
DEA Rescheduling Hearing Halted Over Scheduling Process Report
DEA's chief administrative law judge halted cannabis rescheduling proceedings to review a GAO report showing the agency aligned with HHS in ...
Legislation
Alabama Drops Opposition to Marijuana Rescheduling at State Level
Alabama health officials withdrew their objection to rescheduling marijuana at the state level, aligning with federal moves to reclassify ca...
Legislation
Alabama Withdraws Opposition to Federal Cannabis Rescheduling
Alabama's health department has withdrawn its opposition to federal marijuana rescheduling after legal staff resolved initial concerns about...
Legislation
Court Clears Path for Cannabis Rescheduling Despite Industry Opposition
A federal appeals court rejected attempts by a drug testing association and pharma company to halt cannabis rescheduling, clearing the way f...
Business
Schedule III Shift Opens Door to Cannabis M&A Wave, Attorney Says
An attorney warns cannabis operators that Schedule III rescheduling will trigger industry consolidation as pharmaceutical and agriculture co...